Resources

The International Diabetes Federation (IDF) has developed a new definition of metabolic syndrome to help identify children at risk of developing the syndrome.

Lipoprotein subfraction changes may be at the root of the dyslipidemia accompanying type 2 diabetes and help explain how thiazolidinediones improve carotid intima-media thickness.

Insulin injections may soon be a thing of the past.

For those who eat to combat stress, researchers here may have made a dream come true — an injection that inhibits a well-know peptide, that makes fat melt away, at least in mice.

Australian scientists have discovered why stress can make us fat. New research published in an international journal has revealed that chronic stress triggers the body’s fat cells to grow and multiply.

Beta-blocker therapy can provide statistically significant regression of coronary artery plaque, and slow the progression to coronary atherosclerosis.

An investigational new agent, a highly selective dipeptidyl peptidase-IV (DPP-4) inhibitor, has shown good efficacy and safety in the treatment of type 2 diabetes mellitus, according to results of a phase 1 study.

To often our patients tell us they are not allowed to have any physical activity because of the Cardiovascular concerns. Dr. Sheri Colberg, author of The 7 Step Diabetes Fitness Plan: Living Well and Being Fit with Diabetes, has the right things to do in this weeks feature Exercising Safely …

Last week I had the great opportunity to meet Dr. Phil Wood at the ADA conference in Chicago, we chatted about fat and other things and he prepared this week’s article based on his review of the abstracts. Be sure to read Dyslipidemia In Insulin Resistance: Hypertriglyceridemia And Low HDL …

They were waiting in a long line outside the hall to see Dr Steven Nissen (Cleveland Clinic, OH).